Treatment of insulin-like growth factor deficiency with IGF-I: Studies in humans

被引:9
作者
Backeljauw, PF [1 ]
Chernausek, SD [1 ]
机构
[1] Univ Cincinnati, Coll Med,Cincinnati Childrens Hosp, Ctr Med, Div Endocrinol, Cincinnati, OH 45229 USA
关键词
D O I
10.1159/000090643
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:21 / 27
页数:7
相关论文
共 42 条
[1]  
Backejiauw Philippe E., 1997, Hormone Research (Basel), V48, P40
[2]   Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - A clinical research center study [J].
Backeljauw, PF ;
Underwood, LE ;
Miras, M ;
Arriazu, MC ;
Heinrich, J ;
Ghizzoni, L ;
Blethen, S ;
Donaldson, D ;
Cleveland, W ;
Duncan, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3312-3317
[3]   Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: A clinical research center study [J].
Backeljauw, PF ;
Underwood, LE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1504-1510
[4]   EFFECT OF INTRAVENOUS INSULIN-LIKE GROWTH-FACTOR-I IN 2 PATIENTS WITH LEPRECHAUNISM [J].
BACKELJAUW, PF ;
ALVES, C ;
EIDSON, M ;
CLEVELAND, W ;
UNDERWOOD, LE ;
DAVENPORT, ML .
PEDIATRIC RESEARCH, 1994, 36 (06) :749-754
[5]   FACTORS PREDICTING THE RESPONSE TO GROWTH-HORMONE (GH) THERAPY IN PREPUBERTAL CHILDREN WITH GH DEFICIENCY [J].
BLETHEN, SL ;
COMPTON, P ;
LIPPE, BM ;
ROSENFELD, RG ;
AUGUST, GP ;
JOHANSON, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03) :574-579
[6]   RESISTANCE TO THE GROWTH-PROMOTING AND METABOLIC EFFECTS OF GROWTH-HORMONE IN CHILDREN WITH CHRONIC LIVER-DISEASE [J].
BUCUVALAS, JC ;
CUTFIELD, W ;
HORN, J ;
SPERLING, MA ;
HEUBI, JE ;
CAMPAIGNE, B ;
CHERNAUSEK, SD .
JOURNAL OF PEDIATRICS, 1990, 117 (03) :397-402
[7]   GROWTH-HORMONE INSENSITIVITY ASSOCIATED WITH ELEVATED CIRCULATING GROWTH HORMONE-BINDING PROTEIN IN CHILDREN WITH ALAGILLE SYNDROME AND SHORT STATURE [J].
BUCUVALAS, JC ;
HORN, JA ;
CARLSSON, L ;
BALISTRERI, WF ;
CHERNAUSEK, SD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (06) :1477-1482
[8]   rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM [J].
Carroll, PV ;
Umpleby, M ;
Ward, GS ;
Imuere, S ;
Alexander, E ;
Dunger, D ;
Sonksen, PH ;
RussellJones, DL .
DIABETES, 1997, 46 (09) :1453-1458
[9]  
CHERNAUSEK SD, 1997, JOINT M EUR SOC PED
[10]  
CHERNAUSEK SD, 2004, HORMONE RES S1, V64, P168